Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 1,250 shares at $39.29 ($49K) on 2022-06-15, disclosed to the SEC on 2022-06-17.
Scheduled sale ($49k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |